Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.

Moseley A, LeBlanc M, Freidlin B, Shallis RM, Zeidan AM, Sallman DA, Erba HP, Little RF, Othus M

Open source

DOI
10.1177/17407745241304065
Published
2025 Jun
Container
Clinical trials (London, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17407745241304065,
  title = {Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.},
  author = {Moseley A and LeBlanc M and Freidlin B and Shallis RM and Zeidan AM and Sallman DA and Erba HP and Little RF and Othus M},
  year = {2025},
  journal = {Clinical trials (London, England)},
  doi = {10.1177/17407745241304065},
  url = {https://doi.org/10.1177/17407745241304065}
}

RIS

TY  - JOUR
TI  - Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.
AU  - Moseley A
AU  - LeBlanc M
AU  - Freidlin B
AU  - Shallis RM
AU  - Zeidan AM
AU  - Sallman DA
AU  - Erba HP
AU  - Little RF
AU  - Othus M
PY  - 2025
JO  - Clinical trials (London, England)
DO  - 10.1177/17407745241304065
UR  - https://doi.org/10.1177/17407745241304065
ER  - 

APA

A, M., M, L., B, F., RM, S., AM, Z., DA, S., HP, E., RF, L., & M, O. (2025). Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.. Clinical trials (London, England). https://doi.org/10.1177/17407745241304065

Source records